Afinitor (Rad) Unknown



Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 35.5%
Tuberous Sclerosis 15.8%
Renal Cell Carcinoma 7.7%
Breast Cancer Metastatic 7.1%
Pancreatic Neuroendocrine Tumour 7.1%
Renal Cancer 6.6%
Carcinoid Tumour 2.7%
Neoplasm Malignant 2.7%
Malignant Neoplasm Of Islets Of Langerhans 2.2%
Benign Neoplasm Of Islets Of Langerhans 1.6%
Malignant Urinary Tract Neoplasm 1.6%
Astrocytoma 1.1%
Astrocytoma, Low Grade 1.1%
Brain Neoplasm Benign 1.1%
Breast Cancer Female 1.1%
Carcinoid Syndrome 1.1%
Pancreatic Carcinoma 1.1%
Pancreatic Neuroendocrine Tumour Metastatic 1.1%
Renal Neoplasm 1.1%
Angiomyolipoma 0.5%
Stomatitis 18.5%
Pneumonitis 10.7%
Renal Failure 7.7%
Rash 6.5%
Vomiting 6.5%
Pneumonia 6.0%
Pyrexia 6.0%
Weight Decreased 6.0%
Neoplasm 5.4%
Oedema Peripheral 3.6%
Drug Ineffective 3.0%
Dyspnoea 3.0%
Urticaria 3.0%
Malignant Neoplasm Progression 2.4%
Mouth Ulceration 2.4%
Oral Pain 2.4%
Anaemia 1.8%
Blood Creatinine Increased 1.8%
Blood Glucose Increased 1.8%
Headache 1.8%
Concomitant
Breast Cancer 100.0%
Swollen Tongue 100.0%